Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17909201 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Telbivudine (LdT);   Drug: Adefovir Dipivoxil
2 Unknown  Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
Condition: Hepatitis B
Intervention: Drug: Entecavir

Indicates status has not been verified in more than two years